Using human CD20-transfected murine lymphomatous B cells to evaluate the efficacy of intravitreal and intracerebral rituximab injections in mice.
Mineo, Jean-François
Using human CD20-transfected murine lymphomatous B cells to evaluate the efficacy of intravitreal and intracerebral rituximab injections in mice. [electronic resource] - Investigative ophthalmology & visual science Nov 2008 - 4738-45 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1552-5783
10.1167/iovs.07-1494 doi
Animals
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Murine-Derived
Antigens, CD20--biosynthesis
Antineoplastic Agents--administration & dosage
Brain Neoplasms--drug therapy
Cell Line, Tumor
Cerebrum
Flow Cytometry
Immunohistochemistry
Injections
Lymphoma, Large B-Cell, Diffuse--drug therapy
Mice
Mice, Inbred C3H
Neoplasms, Experimental
Rituximab
Treatment Outcome
Vitreous Body
Using human CD20-transfected murine lymphomatous B cells to evaluate the efficacy of intravitreal and intracerebral rituximab injections in mice. [electronic resource] - Investigative ophthalmology & visual science Nov 2008 - 4738-45 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1552-5783
10.1167/iovs.07-1494 doi
Animals
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Murine-Derived
Antigens, CD20--biosynthesis
Antineoplastic Agents--administration & dosage
Brain Neoplasms--drug therapy
Cell Line, Tumor
Cerebrum
Flow Cytometry
Immunohistochemistry
Injections
Lymphoma, Large B-Cell, Diffuse--drug therapy
Mice
Mice, Inbred C3H
Neoplasms, Experimental
Rituximab
Treatment Outcome
Vitreous Body